|
FDA warns consumers about fraudulent Ebola treatment products
|
14 August 2014 |
|
FDA issues guidance to support the responsible development of nanotechnology products
|
25 June 2014 |
|
FDA launches openFDA to provide easy access to valuable FDA public data
|
13 June 2014 |
|
FDA requires removal of certain restrictions on the diabetes drug Avandia
|
26 November 2013 |
|
FDA approves new drug to treat HIV infection
|
15 August 2013 |
|
FDA alerts companies to stop illegal sale of treatments for diabetes
|
23 July 2013 |
|
FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies
|
27 June 2013 |
|
FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers
|
23 June 2013 |
|
FDA budget requests $4.7 billion
|
11 April 2013 |
|
FDA alerts health care providers of recall of anemia drug Omontys
|
24 February 2013 |
|
FDA approves Pomalyst for advanced multiple myeloma
|
10 February 2013 |
|
FDA approves Gleevec for children with acute lymphoblastic leukemia
|
27 January 2013 |
|
FDA approves new seasonal influenza vaccine made using novel technology
|
16 January 2013 |
|
FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation
|
01 January 2013 |
|
FDA expands use of Xarelto to treat, reduce recurrence of blood clots
|
04 November 2012 |
|
FDA takes action against thousands of illegal Internet pharmacies
|
04 October 2012 |
|
FDA approves new treatment for advanced colorectal cancer
|
27 September 2012 |
|
New FDA task force will support innovation in antibacterial drug development
|
24 September 2012 |
|
FDA approves Lucentis to treat diabetic macular edema
|
12 August 2012 |
|
FDA approves first generic versions of Singulair to treat asthma, allergies
|
05 August 2012 |